Search Results 1071-1080 of 18361 for Hepatitis b

1. Publications - Kelly L. Cox, D.O. - Mayo Clinic

   ... Hepatitis C. AJR Am J Roentgenol. 2022 May; 218 ... B, Elkassem AA, Zhang X. Active Surveillance ... B, Vasanji A, Rini B, Smith AD. Comparative ...

2. A Phase 1 Study of Voruciclib in Subjects With B-Cell Malignancies or AML - Mayo Clinic

   The purpose of this study is to determine the safety and preliminary efficacy of voruciclib as monotherapy in subjects with relapsed or refractory B-cell ...

3. A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of HematopoiEtic Stem Cells for Autologous TransplantatIon in SubjectS With MM - Mayo Clinic

   Has known active Hepatitis B (e.g., Hepatitis B Surface Antigen [HBsAg] reactive) or Hepatitis C (e.g., Hepatitis C Virus [HCV] RNA [qualitative] is detected).

4. Influenza - Vaccines: Gregory A. Poland, Richard B. Kennedy - Mayo Clinic Research

   This study aims to characterize and compare the humoral immune response to trivalent influenza vaccine among people with monoclonal B cell lymphocytosis and ...

5. A Study to Evaluate AL102 to Treat Patients with Progressing Desmoid Tumors - Mayo Clinic

   ... hepatitis B, hepatitis C, or human immunodeficiency virus (HIV) at Screening. 4. Myocardial infarction within 6 months prior to enrollment, greater than ...

6. A Study of Lenalidomide Combined with a Standard Chemotherapy for Treating Patients with Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma - Mayo Clinic

   ... hepatitis B virus (HBV) or hepatitis C virus (HCV). If seropositive because of hepatitis B virus vaccine, then still eligible. Major surgery within 2 weeks of ...

7. An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD - Mayo Clinic

   Seropositive for human immunodeficiency virus, hepatitis B or antibodies to hepatitis B surface and core antigens, or hepatitis C; Has plasma cell leukemia ...

8. Mesenchymal Stem Cell Therapy for Lung Rejection - Mayo Clinic

   Positive screening for HIV Hepatitis B and Hepatitis C. Evidence of liver dysfunction; Liver profile showing alkaline phosphatase higher than 345 u/L, total ...

9. Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma. - Mayo Clinic

   About this study. Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-cell NHL.

10. AZD5305 Vs Placebo In Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents - Mayo Clinic

    Uncontrolled hypertension despite medical management. Evidence of active and uncontrolled hepatitis B and/or hepatitis C. Screening for hepatitis B and ...